Acidum 3-hydroxy-2,4,6-triiodobenzoicum CAS: 53279-72-4
Compositum acidum 3-Hydroxy-2,4,6-triiodobenzoicum imprimis ut medium contrastans ad usus imaginum medicarum adhibetur, praesertim in examinationibus radiographicis ut tomographia computata et angiographia. Visibilitatem quarundam structurarum et organorum auget ut accuratius diagnostica efficiatur.
Praeterea, acidum 3-hydroxy-2,4,6-triiodobenzoicum propter applicationes potentiales in therapia photodynamica (PDT) investigatur. PDT est methodus curationis quae composita lumine activata adhibet ad cellulas cancrosas selective petendas et delendas. Derivata acidi 3-hydroxy-2,4,6-triiodobenzoici eventus promissores in studiis praeclinicis ut photosensibilia pro PDT ostenderunt.
| Compositio | C7H3I3O3 |
| Examen | 99% |
| Aspectus | Pulvis albus |
| Numerus CAS | 53279-72-4 |
| Sarcinatio | Parvus et moles |
| Tempus Vitae | Biennium |
| Depositorium | In loco frigido et sicco servandum |
| Certificatio | ISO. |
Nuntium tuum hic scribe et nobis mitte.






![2,4-Diphenyl-6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,5-triazinum CAS:1219956-23-6](https://cdn.globalso.com/xindaobiotech/@LXIVIBPRLO53RUL5FBL7H784.png)

